Strategic Acquisitions (STQN) Net Cash Flow Growth (1y) (2018 - 2026)
Powered by 
Analysis
Strategic Acquisitions (STQN) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | 149.49% |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | -796.42% |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | -37.39% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -137.32% |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | 591.84% |
| 10 | Strategic Acquisitions | 18.20 Mn | 17.95 Mn | - | 114.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 114.23% |
| Dec 31, 2025 | 42.33% |
| Sep 30, 2025 | 99.87% |
| Jun 30, 2025 | 89.97% |
| Mar 31, 2025 | 8.20% |
| Dec 31, 2024 | 93.73% |
| Mar 31, 2024 | 79.55% |
| Sep 30, 2022 | 5,641.14% |
| Jun 30, 2022 | 11,396.74% |
| Dec 31, 2021 | 80.94% |
| Sep 30, 2021 | 23.22% |
| Jun 30, 2021 | 23.64% |
| Mar 31, 2021 | 75.80% |
| Dec 31, 2020 | 44.86% |
| Sep 30, 2020 | 65.98% |
| Jun 30, 2020 | 37.18% |
| Mar 31, 2020 | 40.67% |
| Dec 31, 2019 | 14.18% |
| Sep 30, 2019 | 38.16% |
| Jun 30, 2019 | -73.11% |